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Abstract
Background: Lifestyle factors may influence the risk of developing pancreatic cancer. Whereas cigarette smoking is
an established risk factor, the effects of high alcohol intake and obesity are more uncertain. The aim of the present
study was to examine the associations of pre-diagnostic anthropometry, alcohol consumption, and smoking habits
with pancreatic cancer risk in a Swedish prospective, population-based cohort, with particular reference to potential
sex differences.
Methods: The studied cohort consists of 28,098 participants, including all incident cases of pancreatic cancer, in the
Malmö Diet and Cancer Study up until December 31, 2013 (n = 163). Non-parametric and chi-squared tests were
applied to compare the distribution of risk factors between cases and non-cases. Cox regression proportional
hazards models were used to estimate the relationship between investigative factors and pancreatic cancer risk.
Anthropometric factors included height, weight, body mass index (BMI), waist and hip circumference, waist-hip
ratio (WHR), and body fat percentage.
Results: BMI was not a significant risk factor for pancreatic cancer, but a higher WHR was significantly associated
with an increased risk in the entire cohort (hazard ratio (HR) 2.36, 95% confidence interval (CI) 1.28–4.35, p for
trend = 0.009). Regular smoking was a significant risk factor among both women (HR 2.62, 95% CI 1.61–4.27) and
men (HR 3.57, 95% CI 1.70–7.47), whereas occasional smoking was a significant risk factor only in women (HR 3.29,
95% CI 1.50–7.19). Passive smoking at work for >20 years was significantly associated with an increased risk in the
entire cohort (HR 1.73, 95% CI 1.15–2.58) and in women selectively (HR 2.01, 95% CI 1.21–3.31). Alcohol
consumption was not a significant risk factor. A significant interaction was found between female sex and age
(p = 0.045), but no other factor, in relation to pancreatic cancer risk.
Conclusions: WHR was the only pre-diagnostic anthropometric factor associated with pancreatic cancer risk, with
no sex-related differences. Regular smoking was confirmed as a significant risk factor in both sexes, whereas
occasional and passive smoking were significant risk factors only in women. Despite the lack of a significant
interaction between smoking and sex in relation with pancreatic cancer risk, potential sex differences should be
considered in future epidemiological studies.
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Background
In 2012, pancreatic adenocarcinoma represented 3% of
all cancer cases in developed countries, non-melanoma
skin cancer excluded [1]. Despite this, it was the fourth
leading cause of cancer-related death, and responsible
for 330,400 deaths worldwide [1]. This demonstrates the
poor prognosis of the disease, with a 5-year overall sur-
vival (OS) of only 4%, and most patients decease less
than 12 months after confirmation of the diagnosis [2].
According to the latest cancer statistics report from the
National Board of Health and Welfare in Sweden (2014),
the peak incidence of pancreatic cancer occurs at an age
of 70–74 years, with the highest incidence rate at 75–
79 years of age [3]. The incidence of pancreatic adeno-
carcinoma has for a long period of time been higher in
men than in women [4–6], but during the last decades
the numbers have become more even, and today there is
no longer any evident sex-related difference [3, 5, 7].
Several risk factors for pancreatic cancer have been re-
ported; however, only a few of them have been con-
firmed more consistently. Tobacco smoking seems to be
the only established modifiable risk factor [7–10], but
high age [2, 4, 8] and heredity for pancreatic cancer
[11, 12] are also often referred to as well-established risk
factors. Diabetes [13–15] and pancreatitis [7, 16, 17] are
thereafter the most commonly studied, but still debated,
risk factors. The possible influence of body constitution
(anthropometry) on the risk of developing pancreatic can-
cer has also been a subject for discussion, and several
studies have demonstrated a significant association be-
tween high body mass index (BMI) and risk of pancreatic
cancer [5–7, 15, 16, 18, 19]. A handful of theories to ex-
plain the plausible correlation between a high BMI and in-
creased risk of pancreatic cancer have been presented.
One of them proposes that the increased insulin resistance
and the elevated levels of circulating insulin in overweight
patients stimulate growth of pancreatic tissue, which
increases the risk of neoplasms to arise [5]. However,
several studies have not been able to demonstrate a
significant association between BMI and pancreatic
cancer risk [20–22].
While active smoking is considered a well-established
risk factor for pancreatic cancer, the risk associated with
passive smoking is less clear. In a previous study based on
The European Prospective Investigation into Cancer and
Nutrition (EPIC) cohort [23], environmental tobacco smok-
ing (ETS) during childhood and at work/at home in adult
life was found to significantly increase the risk of pancreatic
cancer among never smokers, compared to those never ex-
posed. Exposure to ETS at home or at work in adult life
was borderline significantly associated with pancreatic can-
cer risk, but if only exposed during childhood, there was
no increased risk. In that study, potential differences be-
tween sexes regarding ETS were not considered.
The association between alcohol consumption and risk
of pancreatic cancer is also under debate, and the hith-
erto published results are inconclusive. Some studies
demonstrate an increased risk of pancreatic cancer in
heavy alcohol drinkers [24–27], while other studies show
no such association [28–30]. Since alcohol is a well-
known risk factor for recurrent acute pancreatitis (RAP)
[31], as well as chronic pancreatitis (CP) [32], and both
RAP and CP have been validated as significant risk fac-
tors for pancreatic cancer in several studies, a link be-
tween alcohol and pancreatic cancer incidence would
not be unexpected. In a large prospective study from the
USA [32], where the correlation between alcohol con-
sumption and both RAP and CP was investigated, the
correlation between alcohol consumption and CP was
found to be more pronounced in men than in women,
which has been shown in other studies as well [33]. A
number of studies have shown the correlation between
high alcohol consumption and increased pancreatic can-
cer risk to be significant among men [25–27], but very
few have found it to be significant among women [24].
The aim of the present study was to examine the asso-
ciations of anthropometric factors, smoking and alcohol
consumption, with pancreatic cancer risk in the Malmö
Diet and Cancer Study, with particular reference to po-
tential differences between sexes.
Methods
The cohort
The Malmö Diet and Cancer Study (MDCS) is a large pro-
spective, population-based study, which is also part of The
European Prospective Investigation into Cancer and Nutri-
tion (EPIC). MDCS/EPIC is a consecutive cohort including
men and women between 44 and 73 years of age at base-
line, recruited between 1991 and 1996, with a total of
28,098 participants (11,063 men and 17,035 women). The
cohort has been described in detail previously [34–37].
From baseline until last follow-up on December 31,
2013, 172 cases of pancreatic cancer were reported from
the Swedish Cancer Register among the participants. Fol-
lowing review of pathology records, five cases were classi-
fied as either endocrine pancreatic cancer or other types
of non-adenocarcinoma and these cases were transferred
to the group of non-cases. For another four cases, no
pathology reports or medical records were available and
the diagnosis could not be confirmed, and these were ex-
cluded from all analyses, rendering a total number of 163
cases with confirmed pancreatic cancer, 61 men (0.6% of
male participants) and 102 women (0.6% of female partici-
pants). A flowchart of the cohort is shown in Fig. 1.
Statistical methods
Cox regression proportional hazards models were applied
to investigate the impact of age at baseline, sex (entire
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cohort), smoking habits, ETS, alcohol consumption, and
diabetes with pancreatic cancer-free person-years. The
analyses were performed with adjustment for age only or
for all factors except ETS. The potential interaction with
risk factor and sex was tested with the covariates age, sex,
risk factor, and risk factor × sex, and also repeated with
the fully adjusted model. Cox regression proportional haz-
ards models were further applied to estimate the impact
of anthropometric factors on pancreatic cancer-free
person-years adjusted for age, sex, diabetes mellitus (DM),
smoking habits, and alcohol habits. Person-years were cal-
culated by subtracting date at baseline (date of study
entry) from date at diagnosis/date at migration/date of
study end (December 31, 2013).
Included anthropometric variables were height, weight,
BMI, hip circumference, waist circumference, waist-hip ra-
tio (WHR), and body fat percentage, which were all divided
into tertiles for the statistical analyses. Alcohol consump-
tion habits were recorded in grams per day, and smoking
habits denoted as regularly, occasionally, former, and never.
ETS was recorded as exposure during childhood (yes/no),
exposure at home (no/<10 years/10–20 years/>20 years),
or exposure at work (no/<10 years/10–20 years/>20 years).
In the adjusted analyses, diabetes was defined as diag-
nosis of diabetes more than 24 months prior to endpoint
or to the date of pancreatic cancer diagnosis, separating
these participants from the group of participants with
new-onset diabetes, i.e., cases with confirmed diabetes
less than 24 months prior to the endpoint or to the date
of pancreatic cancer diagnosis.
All statistical tests were two sided. p values <0.05 were
considered significant.
All statistical analyses were performed using IBM SPSS
Statistics version 22.0 (SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
The distribution of investigative factors for individuals who
developed pancreatic cancer during follow-up (cases) and
for those who did not (rest of cohort) is shown in Table 1.
Risk of pancreatic cancer in relation with sex, age,
smoking, alcohol consumption, and diabetes
Age-adjusted risk of incident pancreatic cancer in relation
with sex, smoking, ETS at work, alcohol consumption,
and diabetes is shown in Table 2. A significantly higher
risk of incident pancreatic cancer was seen among regular
smokers (hazard ratio (HR) 2.86, 95% confidence interval
(CI) 1.92–4.27) and occasional smokers (HR 2.74, 95% CI
1.40–5.34), compared to never smokers in the entire co-
hort, as well as among women selectively (HR 2.66, 95%
CI 1.64–4.32 and HR 3.35, 95% CI 1.54–7.31, respect-
ively). Among men, only regular smokers were shown to
have a significantly increased risk (HR 3.49, 95% CI 1.67–
7.29) compared to never smokers. Exposure to ETS at
work for more than 20 years was significantly linked to an
increased risk of pancreatic cancer in the entire cohort
(HR 2.03, 95% CI 1.37–3.02), and among women (HR
2.30, 95% CI 1.40–3.77), but not among men. Pancreatic
cancer risk in the entire cohort and among women
Fig. 1 Flowchart of the cohort
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Table 1 Summary of the distribution of risk factors among cases and non-cases
Entire cohort (n = 28,094) Men (n = 11,063) Women (n = 17,031)
Characteristics Rest of cohort PC cases Rest of cohort PC cases Rest of cohort PC cases
n (%) 27,931 (99.4) 163 (0.6) 11,002 (99.4) 61 (0.6) 16,929 (99.4) 102 (0.6)
Sex (%)
Men 11,002 (39.4) 61 (37.4)
Women 16,929 (60.6) 102 (62.6)
Age at baseline (years)
Mean 58.1 60.0 59.2 59.3 57.4 60.5
Median 57.8 59.9 59.1 58.6 56.7 61.1
Smoking (%)
Regularly 6614 (23.7) 60 (36.8) 2602 (23.7) 25 (41.0) 4012 (23.7) 35 (34.3)
Occasionally 1250 (4.5) 11 (6.7) 529 (4.8) 3 (4.9) 721 (4.3) 8 (7.8)
Former smoker 9456 (33.9) 49 (30.1) 4758 (43.2) 23 (37.7) 4698 (27.8) 26 (25.5)
Never smoker 10,599 (37.9) 43 (26.4) 3107 (28.2) 10 (16.4) 7492 (44.3) 33 (32.4)
Missing 12 (0.0) 0 (0.0) 6 (0.1) 0 (0.0) 6 (0.0) 0 (0.0)
Environmental smoking at work
Never 12,171 (43.6) 54 (33.1) 3746 (34.0) 14 (23.0) 8425 (49.8) 40 (39.2)
For <10 years 3277 (11.7) 20 (12.3) 1085 (9.9) 8 (13.1) 2192 (12.9) 12 (11.8)
For 10–20 years 3351 (12.0) 20 (12.3) 1251 (11.4) 8 (13.1) 2100 (12.4) 12 (11.8)
For >20 years 6208 (22.2) 51 (31.3) 3720 (33.8) 25 (41.0) 2488 (14.7) 26 (25.5)
Missing 2924 (10.5) 18 (11.0) 1200 (10.9) 6 (9.8) 1724 (10.2) 12 (11.8)
Environmental smoking at home
Never 13,899 (49.8) 74 (45.4) 6027 (54.8) 31 (50.8) 7872 (46.5) 43 (42.2)
For <10 years 2821 (10.1) 11 (6.7) 974 (8.9) 4 (6.6) 1847 (10.9) 7 (6.9)
For 10–20 years 2973 (10.6) 20 (12.3) 959 (8.7) 9 (14.8) 2014 (11.9) 11 (10.8)
For >20 years 5242 (18.8) 40 (24.5) 1828 (16.6) 11 (18.0) 3414 (20.2) 29 (28.4)
Missing 2996 (10.7) 18 (11.0) 1214 (11.0) 6 (9.8) 1782 (10.2) 12 (11.8)
Environmental smoking during childhood
No 16,375 (58.6) 97 (59.5) 6495 (59.0) 37 (60.7) 9880 (58.4) 60 (58.8)
Yes 8599 (30.8) 48 (29.4) 3293 (29.9) 18 (29.5) 5306 (31.3) 30 (33.3)
Missing 2957 (10.6) 18 (11.0) 1214 (11.0) 6 (9.8) 1743 (10.3) 12 (11.8)
Alcohol (g/day)
Mean 10.7 10.6 15.5 14.7 7.7 8.1
Median 7.2 6.1 11.4 8.6 5.4 4.9
Missing 0 0 0 0 0 0
DM >24 months prior ca/end
Yes 4522 (16.2) 25 (15.3) 2276 (20.7) 14 (23.0) 2246 (13.3) 11 (10.8)
No 23,409 (83.8) 138 (84.7) 8726 (79.3) 47 (77.0) 14,683 (86.7) 91 (89.2)
DM <24 months prior ca/end
Yes 657 (2.4) 27 (16.6) 286 (2.6) 13 (21.3) 371 (2.2) 14 (13.7)
No 27,274 (97.6) 136 (83.4) 10,716 (97.4) 48 (78.7) 16,558 (97.8) 88 (86.3)
Height (cm)
Mean 168.7 168.3 176.4 177.2 163.6 162.9
Median 168.0 168.0 176.0 177.0 164.0 163.0
Missing 41 0 16 0 25 0
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selectively was significantly linked to the time of exposure
to ETS at work. In the group of never smokers, however,
there was no increased risk observed regarding ETS at
work (data not shown). However, if grouping never and
former smokers together, ETS at work for more than
20 years was significantly associated with an increased
pancreatic cancer risk in the entire cohort (HR 1.98, 95%
CI 1.15–3.41) and among women (HR 2.03, 95% CI 1.02–
4.02), but not among men.
High age was significantly associated with an increased
risk of pancreatic cancer in the entire cohort (HR 1.05,
95% CI 1.02–1.07) and among women separately (HR
1.06, 95% CI 1.03–1.09), but not among men. Alcohol
consumption was not significantly associated with risk of
pancreatic cancer, neither in the entire cohort nor in sub-
group analysis according to sex. Prevalent diabetes did not
correlate significantly with risk of pancreatic cancer.
Risk of pancreatic cancer in relation with sex, age,
smoking, ETS at work, alcohol consumption, and diabetes
in the fully adjusted model is shown in Table 3, with simi-
lar HRs for age (HR 1.06, 95% CI 1.03–1.08 in the entire
cohort and HR 1.07, 95% CI 1.05–1.10 among women),
occasional smoking (HR 0.74, 95% CI 1.40–1.35 in the
entire cohort and HR 3.29, 95% CI 1.50–7.19 among
women), and exposure to ETS at work (HR 1.73, 95% CI
1.15–2.58 in the entire cohort and HR 2.01, 95% CI 1.21–
3.31 among women).
In order to assess potential dose-dependent effects, we
also examined the risk of pancreatic cancer according to
tertiles of alcohol consumption in both the age-adjusted
and fully adjusted model, but found no significant asso-
ciations (data not shown).
In the fully adjusted model (Table 3), there was a signifi-
cant interaction between age and female sex (p for inter-
action = 0.045) in relation with pancreatic cancer risk.
There was no significant interaction with any of the other
factors and sex, neither in the age-adjusted nor in the fully
adjusted model.
ETS during childhood and at home were not significantly
associated with pancreatic cancer risk, neither in the entire
cohort nor in sex-stratified analysis (data not shown).
Risk of pancreatic cancer in relation with anthropometric
factors
Risk of incident pancreatic cancer in relation with
anthropometric factors is shown in Table 4.
Table 1 Summary of the distribution of risk factors among cases and non-cases (Continued)
Weight (kg)
Mean 73.4 73.9 81.7 83.2 68.0 68.4
Median 72.0 72.0 81.0 80.0 66.0 66.0
Missing 42 0 16 0 26 0
Body fat (%)
Mean 26.8 27.1 20.8 19.9 30.8 31.5
Median 27.0 29.0 20.0 19.0 31.0 32.0
Missing 172 1 77 0 95 1
Hip (cm)
Mean 98.4 99.3 99.3 99.6 97.9 99.1
Median 98.0 98.0 99.0 98.0 97.0 97.5
Missing 59 0 23 0 36 0
Waist (cm)
Mean 84.1 85.4 93.7 94.7 77.9 79.9
Median 83.0 84.0 93.0 93.0 76.0 78.5
Missing 57 0 23 0 34 0
WHR (cm/cm)
Mean 0.85 0.86 0.94 0.95 0.79 0.80
Median 0.84 0.84 0.94 0.95 0.79 0.80
Missing 62 0 24 0 38 0
BMI (kg/m2)
Mean 25.7 26.0 26.3 26.4 25.4 25.8
Median 25.3 25.3 26.0 25.7 24.7 25.1
Missing 42 0 16 0 26 0
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In the entire cohort, the risk of incident pancreatic
cancer was significantly higher for individuals with a
high WHR (HR 2.36, 95% CI, 1.28–4.35 for tertile 3,
compared with the lowest tertile, p for trend = 0.009).
This significant difference was not observed in subgroup
analysis according to sex. There was a borderline signifi-
cant association of high waist circumference with pan-
creatic cancer risk in the entire cohort (p for trend =
0.063), but not in subgroup analysis according to sex.
Beyond these associations, none of the other examined
factors were found to be significantly associated with an
increased risk of incident pancreatic cancer.
Inclusion of WHR in the fully adjusted model in
Table 3 did not alter the results except for a significantly
increased risk of pancreatic cancer in women compared
to men (HR 2.02, 95% CI, 1.17–3.47) and a borderline
significant interaction between female sex and age in re-
lation with risk (p for interaction = 0.060).
Discussion
In this study, we have examined the associations of an-
thropometric factors, and two other major lifestyle-
related risk factors, smoking and alcohol consumption,
with risk of pancreatic cancer, with particular reference
to potential differences between sexes, in the Malmö
Diet and Cancer study.
As expected, the results confirm smoking as an im-
portant risk factor for incident pancreatic cancer, overall
and in both sexes. This association was particularly evi-
dent in regular smokers, but even occasional smoking
was shown to be significantly associated with risk of
pancreatic cancer in women, but not in men. An add-
itional difference between sexes was observed in that ex-
posure to ETS at work for more than 20 years was
found to be significantly associated with an increased
risk of pancreatic cancer in women, but not in men. This
association remained significant in the group of never
Table 2 Risk of incident pancreatic cancer in relation with sex, age, smoking, alcohol consumption, and prevalent diabetes
Entire cohort Men Women p for interaction
n HR n HR n HR
Sex
Men 11,063 1.00
Women 17,031 1.08 (0.79–1.48)
p 0.636
Age
Years 28,094 1.05 (1.02–1.07) 11,063 1.02 (0.98–1.06) 17,031 1.06 (1.03–1.09) 0.069
p <0.001 0.362 <0.001
Smoking
Never 10,642 1.00 3117 1.00 7525 1.00
Former 9505 1.43 (0.94–2.16) 4781 1.55 (0.74–3.26) 4724 1.46 (0.87–2.45) 0.545
Occasionally 1261 2.74 (1.40–5.34) 532 1.96 (0.54–7.13) 729 3.35 (1.54–7.31) 0.368
Regularly 6674 2.86 (1.92–4.27) 2627 3.49 (1.67–7.29) 4047 2.66 (1.64–4.32) 0.393
p trend <0.001 <0.001 <0.001
Environmental tobacco smoke at work
Never 12,225 1.00 3760 1.00 8465 1.00
For <10 years 3297 1.44 (0.86–2.41) 1093 1.99 (0.83–4.74) 2204 1.23 (0.64–2.34) 0.429
For 10–20 years 3371 1.40 (0.84–2.34) 1259 1.71 (0.72–4.07) 2112 1.25 (0.65–2.34) 0.703
For >20 years 6259 2.03 (1.37–3.02) 3745 1.86 (0.97–3.58) 2514 2.30 (1.40–3.77) 0.256
p trend 0.001 0.082 0.002
Alcohol
g/day 28,094 1.00 (0.99–1.02) 11,063 1.00 (0.98–1.01) 17,031 1.01 (0.99–1.04) 0.352
p 0.638 0.737 0.206
Diabetes >24 months prior pancreatic cancer or endpoint
No 23,547 1.00 8773 1.00 14,774 1.00
Yes 4547 0.86 (0.58–1.36) 2290 1.09 (0.60–1.98) 2257 0.72 (0.38–1.34) 0.366
p 0.576 0.784 0.299
Adjusted for age and sex
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and former smokers; however, in contrast to the results
in the study on the EPIC cohort, no significant correla-
tions to risk were seen in the group of only never
smokers regarding ETS [23]. The finding of a possibly
stronger correlation between smoking and risk of pan-
creatic cancer in women is in line with the results of
several previous studies [10, 15, 23, 38]. The interaction
between smoking and sex was tested in three of these
studies, whereby two found no significant interaction
[23, 38] and one a significant interaction between sex
and duration of smoking [10]. Whether women are more
susceptible to the carcinogenic effects of smoking than
men has been investigated previously, in particular in
studies on lung cancer [39–42]. Collectively, these stud-
ies indicate an increased vulnerability to tobacco carcin-
ogens among women, but whether this is also the case
in pancreatic cancer has not yet been thoroughly investi-
gated. However, the obvious link between smoking and
pancreatic cancer risk, and the herein observed potential
sex differences, notwithstanding the non-significant
interaction between sex and smoking or exposure to
ETS at work, emphasizes the importance to consider
potential sex differences in epidemiological studies.
Moreover, despite the still lower reported percentage of
smokers among women than among men, a plausible ex-
planation for the current equal incidence rate of pancre-
atic cancer between the sexes may well be the rising
female-to-male smoking prevalence ratios in high-
income countries, where pancreatic cancer is more com-
mon than in low-income countries [43, 44].
It is noteworthy that former smokers were not shown
to have an increased risk of incident pancreatic cancer
in the present study. One could ponder that regular
smoking would be a potential risk factor not only when
ongoing but also for a period of time after quitting. A
previous study on the EPIC cohort found that both
Table 3 Risk of incident pancreatic cancer in relation with sex, age, smoking, alcohol consumption, and prevalent diabetes
Entire cohort Men Women p for
interactionn HR n HR n HR
Sex
Men 11,057 1.00
Women 17,025 1.14 (0.81–1.60)
p 0.454
Age
Years 28,079 1.06 (1.03–1.08) 11,054 1.02 (0.99–1.06) 17,022 1.07 (1.05–1.10) 0.045
p <0.001 0.216 <0.001
Smoking
Never 10,642 1.00 3117 1.00 7525 1.00
Former 9505 1.43 (0.94–2.17) 4781 1.58 (0.75–3.33) 4724 1.44 (0.86–2.42) 0.551
Occasionally 1261 2.74 (1.40–5.35) 532 2.00 (0.55–7.31) 729 3.29 (1.50–7.19) 0.367
Regularly 6674 2.87 (1.92–4.28) 2627 3.57 (1.70–7.47) 4047 2.62 (1.61–4.27) 0.397
p trend <0.001 <0.001 <0.001
Environmental tobacco smoke at work
Never 12,222 1.00 3759 1.00 8463 1.00
For <10 years 3296 1.49 (0.89–2.49) 1092 1.95 (0.82–4.66) 2204 1.29 (0.68–2.47) 0.450
For 10–20 years 3370 1.30 (0.78–2.17) 1259 1.53 (0.64–3.66) 2111 1.17 (0.61–2.24) 0.607
For >20 years 6258 1.73 (1.15–2.58) 3744 1.45 (0.74–2.84) 2514 2.01 (1.21–3.31) 0.259
p trend 0.011 0.359 0.013
Alcohol
g/day 28,079 1.00 (0.99–1.01) 11,054 1.00 (0.98–1.01) 17,022 1.01 (0.99–1.03) 0.469
p 0.999 0.528 0.444
Diabetes >24 months prior pancreatic cancer or endpoint
No 23,537 1.00 8768 1.00 14,769 1.00
Yes 4545 0.88 (0.57–1.34) 2289 1.07 (0.59–1.95) 2256 0.72 (0.38–1.34) 0.358
p 0.545 0.819 0.300
Adjusted for sex, age, smoking, alcohol consumption, and diabetes
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regular smokers and former smokers, who had smoked
for more than 25 years or quit less than 5 years prior to
study entry, had an increased risk of incident pancreatic
cancer [23]. Those who quit more than 5 years before
study entry did however not have a significantly in-
creased risk, and there was no significant heterogeneity
between sexes regarding risk for current smokers
compared to never smokers. Among never smokers,
pancreatic cancer risk was also shown to be significantly
increased for those who had been exposed to ETS dur-
ing childhood and at work or at home in their adult life,
compared to those never exposed. Those only exposed
to ETS at home or work in their adult life had a border-
line significantly increased pancreatic cancer risk, but
those only exposed in childhood had no significantly in-
creased risk [23].
Table 4 Risk of incident pancreatic cancer in relation with anthropometric factors
Entire cohort Men Women
n HR n HR n HR
Height tertiles
1 9859 1.00 3711 1.00 6138 1.00
2 9080 0.75 (0.50–1.12) 3838 0.98 (0.53–1.83) 5439 1.04 (0.66–1.65)
3 9102 0.76 (0.44–1.32) 3492 1.17 (0.63–2.18) 5423 1.00 (0.61–1.64)
p trend 0.246 0.630 0.986
Weight tertiles
1 9475 1.00 3819 1.00 5849 1.00
2 9337 1.09 (0.74–1.61) 3504 1.27 (0.69–2.34) 5652 1.15 (0.72–1.82)
3 9228 1.22 (0.79–1.89) 3718 1.11 (0.58–2.13) 5498 1.00 (0.61–1.65)
p trend 0.379 0.731 0.969
BMI tertiles
1 8430 1.00 3463 1.00 6165 1.00
2 9166 1.29 (0.86–1.93) 4099 1.12 (0.61–2.07) 5178 1.28 (0.78–2.09)
3 10,444 1.34 (0.89–2.02) 3479 1.06 (0.54–2.09) 5656 1.34 (0.82–2.19)
p trend 0.167 0.852 0.249
Hip tertiles
1 9395 1.00 3973 1.00 5880 1.00
2 9809 1.50 (1.02–2.20) 3371 0.89 (0.48–1.67) 5377 1.54 (0.94–2.52)
3 8819 1.31 (0.86–1.99) 3690 1.00 (0.54–1.85) 5732 1.35 (0.81–2.27)
p trend 0.213 0.980 0.270
Waist tertiles
1 9144 1.00 3872 1.00 5884 1.00
2 9458 1.47 (0.98–2.21) 3639 1.10 (0.61–2.00) 5509 1.47 (0.90–2.40)
3 9423 1.58 (0.97–2.57) 3523 0.90 (0.47–1.75) 5598 1.35 (0.81–2.26)
p trend 0.063 0.792 0.264
WHR tertiles
1 9294 1.00 3531 1.00 5204 1.00
2 9199 1.34 (0.90–1.99) 3842 1.15 (0.61–2.19) 6458 1.23 (0.75–2.02)
3 9527 2.36 (1.28–4.35) 3660 1.35 (0.71–2.57) 5325 1.35 (0.81–2.26)
p trend 0.009 0.360 0.256
BF% tertiles
1 9415 1.00 3748 1.00 5352 1.00
2 9055 1.12 (0.69–1.83) 3697 0.88 (0.48–1.59) 6476 1.65 (1.00–2.72)
3 9439 1.51 (0.87–2.62) 3535 0.79 (0.42–1.50) 5101 1.33 (0.76–2.33)
p trend 0.108 0.472 0.353
Adjusted for sex, age, smoking, alcohol consumption, and diabetes
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In the present study, alcohol consumption did not differ
significantly between cases and non-cases and was not
found to be significantly associated with pancreatic cancer
risk, neither in the entire cohort nor in sex-stratified ana-
lysis. High alcohol consumption is a well-known risk factor
for pancreatitis [31, 32], and pancreatitis has, in some stud-
ies, been shown to be a risk factor for incident pancreatic
cancer [7, 16, 17]. Along this line, alcohol consumption
can be assumed to influence pancreatic cancer risk, but the
results from several previous studies in this regard are in-
conclusive [24–30]. Potential sex differences are even less
investigated, but, according to existing data, the correlation
appears to be stronger among men [25–27].
Prevalent diabetes has in many studies been highlighted
as a risk factor for pancreatic cancer [13–15]. According
to the results of the present study, however, only new-
onset diabetes was found to be significantly more com-
mon among cases compared with non-cases. This finding
is in line with the expected, as the majority of patients
with pancreatic cancer are known to develop diabetes at
some point due to their disease [2, 4, 8, 45]. Along
this line, it will be of interest to further interrogate
the associations of various factors associated with in-
sulin resistance and pancreatic cancer risk in the
herein investigated cohort.
The observation that age at baseline was higher among
cases compared with the remaining cohort is expected,
since the incidence of pancreatic cancer in Sweden in
2014 peaked at the age of 70–74 years, and the median
age at baseline for the entire cohort of this study was
57.8 years, with the oldest individual being 74 years.
Hence, the individuals entering the study at a higher age
than the median were closer to their age of peak inci-
dence. Of note, this significant difference was only seen
in the entire cohort, and among women, with a signifi-
cant interaction between female sex and age in the fully
adjusted model.
Another purpose of this study was to investigate the
relationship between pre-diagnostic anthropometry and
risk of pancreatic cancer, overall and according to sex.
Apart from the finding of a high WHR being signifi-
cantly associated with pancreatic cancer risk in the en-
tire cohort, but not in sex-stratified analysis, none of the
other investigated anthropometric factors was signifi-
cantly associated with pancreatic cancer risk, neither in
the entire cohort nor in sex-stratified analyses. Accord-
ing to the existing literature, BMI has been proposed as
the anthropometric factor with the strongest association
to risk of pancreatic cancer, but yet there is no definite
consensus [5–7, 15, 16, 18, 19]. Several of the previous
studies reporting significant correlations between over-
weight/obesity and an increased risk of pancreatic cancer
have shown this to apply to both sexes [5, 19]; however,
in the pooled study performed by Genkinger et al.,
modest differences between sexes were observed regard-
ing the association of BMI with pancreatic cancer risk
[19]. In a previous study within the EPIC cohort, includ-
ing incident cases in the MDCS up until April 2004, a
higher WHR as well as a larger waist circumference was
observed to significantly increase the risk of pancreatic
cancer, while there were no significant associations be-
tween BMI and risk of pancreatic cancer [20]. In light of
the herein presented results, it would be of interest to
re-examine the associations of pre-diagnostic anthro-
pometry with pancreatic cancer risk in the EPIC cohort,
with a more recent follow-up on incident cases.
Of note, the number of female participants in the
MDCS is higher than the number of male participants,
which resulted in a higher number of female than
male pancreatic cancer cases. However, the incidence
rate of pancreatic cancer did not differ significantly
between men and women, which confirms the con-
temporary equal incidence rate of pancreatic cancer
between the sexes [1, 3].
Conclusions
In this study, regular smoking was confirmed to be a
strong risk factor for pancreatic cancer in both sexes,
but the relationship between occasional smoking and
long-term environmental exposure with pancreatic can-
cer risk was only observed in women. Despite the lack of
a significant interaction with sex, these findings suggest
that the carcinogenic effects of smoking may be more
hazardous in women and emphasize the importance of
taking potential sex differences into consideration in epi-
demiological studies and prevention efforts. Further-
more, the results from this study demonstrate that a
high waist-hip ratio was the only pre-diagnostic an-
thropometric factor being significantly associated with
pancreatic cancer risk, with no difference between sexes.
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